Function Impact News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Function Impact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Function Impact Today - Breaking & Trending Today

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

Published: April 7, 2024

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 7, 2024--

Source: eagletribune.com

Related Topics:

United KingdomUnited StatesChristine Regan LindenboomJosh BrodskyAkshay DesaiSimon FoxAlnylam PharmaceuticalsHealth Promotion SeriesZilebesiran Program Lead At AlnylamWorld Health OrganizationJournal Of The American College CardiologySecurities ExchangeAmerican College Of CardiologyExchange CommissionAlnylam Pharmaceuticals NasdaqHeart Failure ProgramAlnylam Pharmaceuticals IncAnnual ScientificHour MeanOrthostatic HypotensionRepeat MeasureFunction ImpactVice PresidentZilebesiran Program LeadRenin Angiotensin Aldosterone System